Close

DXCM Financial Facts

Selling, general and administrative: 75.7M
Product cost of sales: 47.5M
See Full Income Statement

Commitments and contingencies (Note 4): 0
Cash and cash equivalents: 97.7M
See Full Balance Sheet

DexCom, Inc. (DXCM) Earnings

  |   Expand Research on DXCM
Next EPS Date 7/25/24 *Est. EPS Growth Rate +88.2% *Last Qtr.
Average EPS % Beat Rate +32.4% Revenue Growth Rate +24.2% *Last Qtr.
Average % Move 1-Wk after EPS +0.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/10 Q310 -$0.23-$0.18 -$0.05N/AN/A N/A Details
3/3/11 Q410 -$0.16-$0.19 +$0.03$15.6M$14.69M N/A Details
5/3/11 Q111 -$0.19-$0.19 $0.00$14.2M$14.53M N/A Details
8/3/11 Q211 -$0.11-$0.12 +$0.01$21.4M$20.83M N/A Details
11/2/11 Q311 -$0.20-$0.16 -$0.04$18.3M$19.05M N/A Details
2/23/12 Q411 -$0.18-$0.17 -$0.01$22.4M$21.63M N/A Details
5/2/12 Q112 -$0.21-$0.19 -$0.02$20.1M$19.88M N/A Details
8/6/12 Q212 -$0.21-$0.20 -$0.01$23.5M$22.24M N/A Details